Calcitriol and cholecalciferol effect on cardiac biomarkers

Phase 3

Recruiting

• Conditions: Coronary artery disease.; Atherosclerotic heart disease of native coronary artery; I25.1

• Registration Number: IRCT20150518022306N3
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

All patients diagnosed with Coronary artery disease who hospitalized due to performing elective percutaneous Coronary Intervention (angioplasty with stent)
Vitamin D level of less than 30 ng/m

Exclusion Criteria

patients with myocardial infarction or history of coronary artery bypass graft in last 3 months
patients with history of vitamin D supplementation in the last 1 month prior to hospitalization
patients with history of unsuccessful PCI

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison any change in level of troponin-I. Timepoint: at baseline and 24 hours after Percutaneous Coronary Intervention. Method of measurement: serum level.;Comparison any change in level of High Sensitivity C-Reactive Protein (hsCRP). Timepoint: At baseline and 24 hours after Percutaneous Coronary Intervention. Method of measurement: serum level.;Comparison any change in level of Creatine kinase-MB. Timepoint: At baseline and 24 hours after Percutaneous Coronary Intervention. Method of measurement: serum level.